Common Stock, Shares, Issued of SANGAMO THERAPEUTICS, INC from 31 Dec 2010 to 31 Dec 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
SANGAMO THERAPEUTICS, INC quarterly Common Stock, Shares, Issued in shares history and change rate from 31 Dec 2010 to 31 Dec 2024.
  • SANGAMO THERAPEUTICS, INC Common Stock, Shares, Issued for the quarter ending 31 Dec 2024 was 212,837,679, a 19% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Change (%)

SANGAMO THERAPEUTICS, INC Quarterly Common Stock, Shares, Issued (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 212,837,679 +34,704,131 +19% 31 Dec 2024 10-K 17 Mar 2025 2024 FY
Q4 2023 178,133,548 +11,340,228 +6.8% 31 Dec 2023 10-K 17 Mar 2025 2024 FY
Q4 2022 166,793,320 +20,871,790 +14% 31 Dec 2022 10-K 13 Mar 2024 2023 FY
Q4 2021 145,921,530 +3,858,327 +2.7% 31 Dec 2021 10-K 23 Feb 2023 2022 FY
Q4 2020 142,063,203 +26,090,495 +22% 31 Dec 2020 10-K 24 Feb 2022 2021 FY
Q4 2019 115,972,708 +13,785,237 +13% 31 Dec 2019 10-K 24 Feb 2021 2020 FY
Q4 2018 102,187,471 +16,588,937 +19% 31 Dec 2018 10-K 28 Feb 2020 2019 FY
Q3 2018 101,839,668 +17,734,877 +21% 30 Sep 2018 10-Q 08 Nov 2018 2018 Q3
Q2 2018 101,623,521 +18,143,982 +22% 30 Jun 2018 10-Q 08 Aug 2018 2018 Q2
Q1 2018 87,041,208 +15,288,795 +21% 31 Mar 2018 10-Q 10 May 2018 2018 Q1
Q4 2017 85,598,534 +14,726,632 +21% 31 Dec 2017 10-K 01 Mar 2019 2018 FY
Q3 2017 84,104,791 +13,482,954 +19% 30 Sep 2017 10-Q 09 Nov 2017 2017 Q3
Q2 2017 83,479,539 +12,873,276 +18% 30 Jun 2017 10-Q 09 Aug 2017 2017 Q2
Q1 2017 71,752,413 +1,352,377 +1.9% 31 Mar 2017 10-Q 10 May 2017 2017 Q1
Q4 2016 70,871,902 +517,294 +0.74% 31 Dec 2016 10-K 01 Mar 2018 2017 FY
Q3 2016 70,621,837 +579,079 +0.83% 30 Sep 2016 10-Q 27 Oct 2016 2016 Q3
Q2 2016 70,606,263 +803,566 +1.2% 30 Jun 2016 10-Q 04 Aug 2016 2016 Q2
Q1 2016 70,400,036 +902,780 +1.3% 31 Mar 2016 10-Q 05 May 2016 2016 Q1
Q4 2015 70,354,608 +1,292,214 +1.9% 31 Dec 2015 10-K 28 Feb 2017 2016 FY
Q3 2015 70,042,758 +1,709,485 +2.5% 30 Sep 2015 10-Q 30 Oct 2015 2015 Q3
Q2 2015 69,802,697 +1,701,218 +2.5% 30 Jun 2015 10-Q 06 Aug 2015 2015 Q2
Q1 2015 69,497,256 +1,674,954 +2.5% 31 Mar 2015 10-Q 28 Apr 2015 2015 Q1
Q4 2014 69,062,394 +6,818,502 +11% 31 Dec 2014 10-K 18 Feb 2016 2015 FY
Q3 2014 68,333,273 +6,912,618 +11% 30 Sep 2014 10-Q 28 Oct 2014 2014 Q3
Q2 2014 68,101,479 +14,127,027 +26% 30 Jun 2014 10-Q 29 Jul 2014 2014 Q2
Q1 2014 67,822,302 +14,275,986 +27% 31 Mar 2014 10-Q 07 May 2014 2014 Q1
Q4 2013 62,243,892 +9,185,367 +17% 31 Dec 2013 10-K 25 Feb 2015 2014 FY
Q3 2013 61,420,655 +8,556,984 +16% 30 Sep 2013 10-Q 04 Nov 2013 2013 Q3
Q2 2013 53,974,452 +1,252,138 +2.4% 30 Jun 2013 10-Q 02 Aug 2013 2013 Q2
Q1 2013 53,546,316 +959,726 +1.8% 31 Mar 2013 10-Q 09 May 2013 2013 Q1
Q4 2012 53,058,525 +503,730 +0.96% 31 Dec 2012 10-K 24 Feb 2014 2013 FY
Q3 2012 52,863,671 +391,739 +0.75% 30 Sep 2012 10-Q 02 Nov 2012 2012 Q3
Q2 2012 52,722,314 +277,857 +0.53% 30 Jun 2012 10-Q 03 Aug 2012 2012 Q2
Q1 2012 52,586,590 31 Mar 2012 10-Q 07 May 2012 2012 Q1
Q4 2011 52,554,795 +7,177,056 +16% 31 Dec 2011 10-K 26 Feb 2013 2012 FY
Q3 2011 52,471,932 30 Sep 2011 10-Q 04 Nov 2011 2011 Q3
Q2 2011 52,444,457 30 Jun 2011 10-Q 05 Aug 2011 2011 Q2
Q4 2010 45,377,739 31 Dec 2010 10-K 23 Feb 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.